Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors
The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to rheumatoid arthritis.
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
18.12.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to rheumatoid arthritis. |
|---|---|
| AbstractList | The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to rheumatoid arthritis. |
| Author | GADDAM BAPU POLISETTI DHARMA RAO GUZEL MUSTAFA MJALLI ADNAN M.M KOSTURA MATTHEW J |
| Author_xml | – fullname: GADDAM BAPU – fullname: KOSTURA MATTHEW J – fullname: GUZEL MUSTAFA – fullname: MJALLI ADNAN M.M – fullname: POLISETTI DHARMA RAO |
| BookMark | eNrjYmDJy89L5WTwDynKTK5MzslMVnDOzy3IL81LKVZILFbwzU8pzUksyS8qVshPUwjxc9NNzCnISFQIrswryUgtzgQqyksBKQxwcTVR8MzLyEzKBKnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoYmxuaGRqYGjobGxKkCAN5DOF8 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2014371250A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2014371250A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:54:23 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2014371250A13 |
| Notes | Application Number: US201414477302 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141218&DB=EPODOC&CC=US&NR=2014371250A1 |
| ParticipantIDs | epo_espacenet_US2014371250A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20141218 |
| PublicationDateYYYYMMDD | 2014-12-18 |
| PublicationDate_xml | – month: 12 year: 2014 text: 20141218 day: 18 |
| PublicationDecade | 2010 |
| PublicationYear | 2014 |
| RelatedCompanies | HIGH POINT PHARMACEUTICALS, LLC |
| RelatedCompanies_xml | – name: HIGH POINT PHARMACEUTICALS, LLC |
| Score | 2.9600885 |
| Snippet | The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| Title | Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141218&DB=EPODOC&locale=&CC=US&NR=2014371250A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2K7ttv6UMT1gynsA9fJ3kabJliQdKwV2X_vJXS6p70lueNIDi6_S3KXA3h0EcYoN009Y_Lqhrlcd3sdqiPWcYtyq0tdme88GneHc_tt4Swa8LXNhVH_hP6ozxHRoijae6X269X_JVagYivLpzTHoeI5ir1Aq0_Hpm0iZGnBwAunk2Dia77vzWfa-F3RrB6iufGCZ6UDdKR7MgAs_BjIvJTVLqhEp3A4RXmiOoMGEy049re111pwNKqfvLFZW195DpMYN60NxRkSacayIFJJkpKMikwW4SrWJSk4iceRrjJoyWwj0L0rc2QSmWScBqFNXsVnnuaS-wIeojD2hzrObPmniOV8trsM6xKaohDsCkiCSuWOQx3XZTZPkrRDOyk3s76dsIwZxjW090m62U--hRPZlUEcZr8NzWr9ze4Qiqv0XmnwF9ADjU0 |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYP1CaavS0ytgF7IEb2EVA2iAzDG9m6Ni4xG2Ezhv_eawPKE29N79JcL7n-2ut9ADxaCGOUa5qaMOG6YRZXrU6Lqoh1XKdcb1NL5Dv7QXswM17n5rwCX9tcGFkn9EcWR0SLomjvpTyvl_9OLEfGVhZPcYpT-bMX9hxl8zrWDA0hS3H6PXcydsa2Ytu92VQJ3iVN7yCaN1_wrXSAl-yuqLTvfvRFXspyF1S8Ezic4HpZeQoVltWhZm97r9XhyN98eeNwY33FGYxDPLTWFCUkwoxFQ6SCRAXx80Q04cpXBck5CQNPlRm0ZLrO8HpXpMiUJYJx4rgGGWafaZwK7nN48NzQHqgo2eJPEYvZdHcb-gVUszxjl0AiVCo3TWpaFjN4FMUt2oq5lnSNiCWs2byCxr6VrveT76E2CP3RYjQM3m7gWJBEQIfWbUC1XH2zW4TlMr6T2vwFmMaQPQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Tricyclic+Compounds+as+Modulators+of+TNF-alpha+Synthesis+and+as+PDE4+Inhibitors&rft.inventor=GADDAM+BAPU&rft.inventor=KOSTURA+MATTHEW+J&rft.inventor=GUZEL+MUSTAFA&rft.inventor=MJALLI+ADNAN+M.M&rft.inventor=POLISETTI+DHARMA+RAO&rft.date=2014-12-18&rft.externalDBID=A1&rft.externalDocID=US2014371250A1 |